Emily Kaplan

MetFix

Emily Kaplan is an investigative journalist and the CEO of MetFix. Her work involves reporting on scientific corruption and examining the barriers to implementing metabolic therapies in clinical cancer care.

8 claims checked on air: 2 context 3 overstated 2 supported 1 unverified

What they said on air - unverified

0:57:10unverifiedvery lowEmily Kaplan and Dr. Seyfried: The oncology field must under

The American Medical Association generates the majority of its revenue from the licensing and sale of proprietary billing codes (CPT codes).

"No, actually they make most of their money off of billing codes. So they have proprietary billing codes they sell to insurance companies, hospitals, doctor's offices." (said at 0:57:10)

A search of biomedical databases (PubMed and Europe PMC) yielded no peer-reviewed studies or publications evaluating the specific revenue breakdown or financial auditing of the American Medical Association's licensing and sales of Current Procedural Terminology (CPT) codes. This is primarily an institutional financial/accounting matter typically disclosed in IRS Form 990 filings and annual reports rather than indexed biomedical literature. Consequently, the claim is unverified within the indexed scientific literature, which does not prove the claim false.

Fact-checked episodes

Publications

No PubMed publication profile has been built for this speaker yet.